Allergy-Rf™ is a natural health product made from certified organic eggs (white and yolk only) obtained from a special species of Japanese quails (Coturnix coturnix). The quails are fed a proprietary, scientifically-formulated diet under strict guidelines in which no antibiotics, hormones or pharmaceuticals are used. It was originally developed by a team of European scientists after significant scientific research validating the efficacy of some quail egg glycoproteins in the relief of respiratory distress caused by seasonal and environmental allergens. Allergy-Rf is made in a GMP certified facility in Europe.
Many allergens such as pollen, dust mites, mold, animal hair and dander contain specific proteins called tryptases. Upon allergen inhalation, tryptases stimulate the release of histamines – the chemical released by the immune system as the body defends against invading substances – causing allergy symptoms such as itchy nose, watery eyes, runny nose, etc.
Allergy-Rf is a natural histamine blocker – it inhibits the tryptases from creating the physiological reactions that release the histamines causing full-blown allergic response.
A double-blind, placebo controlled clinical study has shown that relief of allergy symptoms occurred within 15 minutes of taking Allergy-Rf, does not cause drowsiness.
Effects of quail eggs in the relief of pollen-induced seasonal rhinitis (sneezing, nasal congestion, and itchy nose) were evaluated in 3 human studies. In all trials, consumption of quail egg homogenates resulted in statistically significant reduction in the intensity of allergy symptoms. A recently completed randomized, double-blind, placebo-controlled trial conducted by an independent, US-based contract research organization determined the efficacy and safety of Allergy-Rf in healthy subjects exposed to a standardized allergenic challenge. Subjects received one acute dose of either Allergy-Rf or placebo given concomitantly to a standardized amount of a mixture of outdoor and indoor allergens including grass and tree pollen, dust mites, as well as cat and dog dander.
Users demonstrated significantly improved reactions versus those who took the placebo. This indicated that the subjects on Allergy-Rf were able to breathe significantly better through their nose than those on placebo. The beneficial effects were apparent as early as 15 minutes after consumption of the tablets. Subjects’ perceived feelings of allergy related nasal discomforts such as stuffy nose, itchy nose, watery eyes and itchy eyes were also significantly reduced in the Allergy-Rf group. No adverse events occurred during the study.